Mona Fikry | Cognitive Neuroscience | Best Academic Researcher Award

Published on by Neuroscientists

Assist. Prof. Dr. Mona Fikry | Cognitive Neuroscience | Best Academic Researcher Award

Assist. Prof. Dr.  Mona Fikry, Faculty of Pharmacy-Cairo University, Egypt.

Dr. Mona Fikry Said, Assistant Professor of Pharmaceutical Chemistry at Cairo University, stands out as a dedicated educator, researcher, and mentor in the field of medicinal chemistry. Her academic journey reflects a blend of deep scientific knowledge and practical teaching expertise. She has supervised numerous postgraduate theses and published extensively in prestigious journals. Her research, particularly in the synthesis and pharmacological evaluation of novel compounds for neurodegenerative diseases, highlights her commitment to addressing real-world health challenges. Beyond her publications, Dr. Said’s influence extends through academic collaboration, curriculum development, and mentorship.

Profile

Google Scholar

🎓 Early Academic Pursuits

Dr. Mona Fikry Said began her academic journey with a strong foundation in pharmaceutical sciences, eventually channeling her passion for medicinal chemistry into advanced academic and research endeavors. Her early commitment to learning laid the groundwork for a career dedicated to both academic excellence and scientific innovation. This formative stage was marked by rigorous study and a growing interest in drug design and discovery, which shaped her professional focus.

🧪 Professional Endeavors

Currently serving as an Assistant Professor of Pharmaceutical Chemistry at the Faculty of Pharmacy, Cairo University, Dr. Said has become a respected educator and mentor in her field. She has been actively involved in teaching a wide array of pharmaceutical chemistry courses and guiding numerous master’s and doctoral students through their theses. Her role extends beyond instruction, as she also participates in academic advising and serves as an external examiner for other institutions.

🔬 Contributions and Research Focus

Dr. Said’s research is deeply rooted in pharmaceutical chemistry, with a particular focus on the development of novel bioactive compounds. Her most recent completed project, “Probing new 3-hydrazinyl indole phenacetamide derivatives as multitarget anti-Alzheimer: Synthesis, in vivo, in vitro, and in silico studies,” exemplifies her multidisciplinary approach to drug discovery. She integrates synthesis, pharmacological testing, and computational modeling to explore new therapeutic avenues, especially for neurodegenerative diseases.

🏅 Accolades and Recognition

While not always publicly documented, Dr. Said’s scientific contributions are widely acknowledged through her publications in high-impact journals such as European Journal of Medicinal Chemistry, Molecular Diversity, Bioorganic Chemistry, and Future Medicinal Chemistry. Her expertise is recognized by her academic peers, and her involvement in national academic programs highlights her standing in the pharmaceutical education community.

🌐 Impact and Influence

Through her publications in SCI and Scopus-indexed journals, Dr. Said has significantly contributed to the body of knowledge in pharmaceutical chemistry. Her work bridges theoretical research and practical applications, influencing both the academic landscape and the early stages of pharmaceutical development. By mentoring postgraduate students and collaborating across institutions, she has helped cultivate a new generation of researchers in Egypt and beyond.

📘 Legacy and Future Contributions

Dr. Said’s lasting impact lies not only in her research but also in her educational leadership. With each class she teaches and each thesis she supervises, she sows the seeds for future advancements in medicinal chemistry. Her continued involvement in clinical academic programs and university examinations ensures that her influence will resonate across institutions for years to come. Looking forward, her research aims to expand into more diverse therapeutic targets, further strengthening Cairo University’s role in pharmaceutical innovation.

🧬 Research Vision in Pharmaceutical Chemistry

With an enduring commitment to discovery, Dr. Mona Fikry Said envisions a research future driven by interdisciplinary collaboration and the integration of cutting-edge techniques. Her dedication to the design and synthesis of multitarget agents reflects a broader mission to combat complex diseases like Alzheimer’s. In doing so, she positions herself at the forefront of modern pharmaceutical chemistry, where innovation and impact go hand in hand.

Publication

  • Synthesis of novel 1,3,4-trisubstituted pyrazoles as anti-inflammatory and analgesic agents
    FA Ragab, NMA Gawad, HH Georgey, MF Said
    2013

 

  • Design and synthesis of ibuprofen-quinoline conjugates as potential anti-inflammatory and analgesic drug candidates
    AM Ghanim, AS Girgis, BM Kariuki, N Samir, MF Said, A Abdelnaser, …
    2022

 

  • Pyrazolone derivatives: Synthesis, anti-inflammatory, analgesic, quantitative structure–activity relationship and in vitro studies
    FAF Ragab, NM Abdel-Gawad, HH Georgey, MF Said
    2013

 

  • Synthesis and selective inhibitory effects of some 2-oxindole benzenesulfonamide conjugates on human carbonic anhydrase isoforms CA I, CA II, CA IX and CAXII
    RF George, MF Said, S Bua, CT Supuran
    2020

 

  • Synthesis, molecular modelling and QSAR study of new N-phenylacetamide-2-oxoindole benzensulfonamide conjugates as carbonic anhydrase inhibitors
    MF Said, RF George, A Petreni, CT Supuran, NM Mohamed
    2022

 

  • Synthesis and molecular docking of new imidazoquinazolinones as analgesic agents and selective COX-2 inhibitors
    HH Hassanein, HH Georgey, MA Fouad, AM El Kerdawy, MF Said
    2017

 

  • New NSAID conjugates as potent and selective COX-2 inhibitors: Synthesis, molecular modeling and biological investigation
    RM Bokhtia, SS Panda, AS Girgis, N Samir, MF Said, A Abdelnaser, …
    2023

 

  • Development of Isatin‐Based Schiff Bases Targeting VEGFR‐2 Inhibition: Synthesis, Characterization, Antiproliferative Properties, and QSAR Studies
    IA Seliem, SS Panda, AS Girgis, QL Tran, MF Said, MS Bekheit, …
    2022

 

  • Synthesis and computational studies of novel fused pyrimidinones as a promising scaffold with analgesic, anti-inflammatory and COX inhibitory potential
    MF Said, HH Georgey, ER Mohammed
    2021

 

  • Novel Curcumin Mimics: Design, Synthesis, Biological Properties and Computational Studies of Piperidone‐Piperazine Conjugates
    MA Youssef, SS Panda, DR Aboshouk, MF Said, A El Taweel, M GabAllah, …
    2022

 

✅ Conclusion

Through her unwavering dedication to pharmaceutical chemistry, Dr. Said has carved out a meaningful role in academia and research. Her work not only advances scientific understanding but also nurtures future innovators in the field. With a strong foundation in both teaching and research, and a vision for multidisciplinary innovation, she is poised to continue making impactful contributions to drug discovery and pharmaceutical education in the years to come.

Tahereh Momeni Isfahani | Neuroscience & Education | Best Researcher Award

Published on by Neuroscientists

Assoc. Prof. Dr. Tahereh Momeni Isfahani | Neuroscience & Education | Best Researcher Award

Assoc. Prof. Dr. Tahereh Momeni Isfahani,  Ar.C.,Arak Branch, Islamic Azad University,  Iran.

Dr. Taherh Momeni Isfahani is a distinguished chemist and academic affiliated with the Islamic Azad University, Arak Branch. Her academic journey is rooted in Iran’s top institutions, where she earned her B.Sc., M.Sc., and Ph.D. in Chemistry. Her research focuses on the development of advanced electrochemical sensors, with a strong emphasis on medical and environmental applications. Her recent work, involving a novel pencil graphite electrode electrospun with Poly-Sudan Black-B for dopamine analysis, has garnered significant recognition and was provisionally nominated for the Best Researcher Award. In addition to her active research output, she contributes to the scientific community as a faculty member and mentor, fostering innovation and academic excellence within her field.

Profile

Google Scholar

 

🎓 Early Academic Pursuits

Dr. Taherh Momeni Isfahani’s academic journey began with a strong foundation in chemistry, which she pursued with unwavering dedication at the Islamic Azad University of Arak, Iran. Her passion for analytical chemistry was evident from her undergraduate years, and she continued to build on that foundation with a Master’s degree from the University of Isfahan, where she worked on the development of an optical sensor for nickel (II) ion detection. Her intellectual curiosity and academic discipline culminated in a Ph.D. in Chemistry from her alma mater in Arak, where she focused on advanced spectrophotometric techniques and chemometric methods for the simultaneous determination of cations and equilibrium studies.

🧪 Professional Endeavors

Dr. Momeni currently serves as a member of the Science Committee at the Arak Branch of the Islamic Azad University, where she contributes both as a researcher and academic. Her professional role reflects a balance between teaching, research, and academic leadership. With deep expertise in analytical chemistry and instrumentation, she plays a pivotal role in guiding students and contributing to the scientific community through her research initiatives. Her involvement in the academic landscape of Iran has enriched the scientific discourse within her institution and beyond.

🔬 Contributions and Research Focus

A core focus of Dr. Momeni’s work lies in electrochemical sensing and analytical techniques, particularly for biomedical applications. Her research includes the fabrication of electrochemical sensors, development of polymeric membrane-based sensors, and exploration of chemometric methods in chemical analysis. In her most recent study, she designed a sensitive electrochemical sensor using a pencil graphite electrode electrospun with poly-Sudan Black-B, aimed at detecting dopamine in plasma samples—a critical advancement in bioanalytical chemistry. Her work stands at the intersection of innovation and application, addressing real-world challenges in medical diagnostics and environmental monitoring.

🏅 Accolades and Recognition

Dr. Momeni’s recent publication in the Journal of Cluster Science (2025) has garnered recognition and was provisionally nominated for the prestigious ‘Best Researcher Award’. This acknowledgment highlights the scientific merit and practical value of her research. It serves as a testament to her perseverance and commitment to pushing the boundaries of sensor development in analytical chemistry. Her growing list of publications reflects both depth and relevance in her chosen field.

🌍 Impact and Influence

Through her contributions, Dr. Momeni has significantly influenced the field of analytical chemistry within the academic and applied research settings in Iran. Her work has not only advanced sensor technologies but also impacted how chemical analysis is approached in complex biological and environmental systems. By designing cost-effective and accessible sensing platforms, she paves the way for more accurate and affordable diagnostic tools, especially in regions with limited access to high-end technology.

👩‍🔬 Legacy and Future Contributions

Dr. Momeni’s research legacy is rooted in her dedication to solving practical problems through precise scientific inquiry. As she continues to explore advanced materials and electrode technologies, her future work promises to delve deeper into biosensor innovation and multi-ion detection systems. Her mentorship of young scientists and contributions to curriculum development ensure that her impact extends beyond the lab, inspiring the next generation of chemists and researchers.

Publication

  • Spectrophotometric determination of mercury in water samples after cloud point extraction using nonionic surfactant Triton X-114 – A Niazi, T Momeni-Isfahani, Z Ahmari – 2009

 

  • Decolorization of crystal violet from aqueous solutions by a novel adsorbent chitosan/nanodiopside using response surface methodology and artificial neural network-genetic – SG Nasab, A Semnani, A Teimouri, MJ Yazd, TM Isfahani, S Habibollahi – 2019

 

  • Removal of Congo red from aqueous solution by hydroxyapatite nanoparticles loaded on zein as an efficient and green adsorbent: response surface methodology and artificial – S Ghanavati Nasab, A Semnani, A Teimouri, H Kahkesh, … – 2018

 

  • Development of an optical chemical sensor based on 2-(5-bromo-2-pyridylazo)-5-(diethylamino) phenol in Nafion for determination of nickel ion – MK Amini, T Momeni-Isfahani, JH Khorasani, M Pourhossein – 2004

 

  • Prediction of oral acute toxicity of organophosphates using QSAR methods – M Kianpour, E Mohammadinasab, TM Isfahani – 2021

 

  • Spectrophotometric determination of acidity constants of 2-(2-Thiazolylazo)-Cresol in various water–organic solvent media mixtures using chemometrics methods – T Momeni-Isfahani, A Niazi – 2014

 

  • Superparamagnetic core‐shell metal–organic framework Fe3O4@Ni‐MOF as efficient catalyst for oxidation of 1,4‐dihydropyridines using hydrogen peroxide – M Janani, MA Senejani, TM Isfahani – 2021

 

  • Hofmann N‐alkylation of aniline derivatives with alcohols using ferric perchlorate immobilized on SiO2 as a catalyst through Box–Behnken experimental design – M Ghanimati, M Abdoli Senejani, TM Isfahani, MA Bodaghifard – 2018

 

  • Quantitative Structure-Property Relationship (QSPR) investigation of camptothecin drugs derivatives – N Ahmadinejad, F Shafiei, TM Isfahani – 2018

 

  • Application of robust syringe-to-syringe dispersive liquid-phase microextraction method for preconcentration and determination of mercury with the aid of an experimental design – M Hayati, M Ramezani, G Rezanejade Bardajee, T Momeni Isfahani – 2022

 

✅ Conclusion

Dr. Taherh Momeni Isfahani exemplifies the qualities of a dedicated and innovative researcher. Her consistent focus on solving real-world problems through advanced sensor technologies, coupled with her academic contributions and recent recognition at an international level, makes her an ideal candidate for the Best Researcher Award. Her work not only advances the field of analytical chemistry but also inspires future research aimed at practical, impactful solutions in healthcare and environmental monitoring. With her strong academic foundation, innovative mindset, and growing influence, Dr. Momeni is poised to continue making meaningful contributions to science and society.

John Vincent Sanchez Orti | Biomarkers in Neurocognition | Young Scientist Award

Published on by Neuroscientists

Dr. John Vincent Sanchez Orti | Biomarkers in Neurocognition | Young Scientist Award

Dr. Joan Vicent Sánchez Ortí, Health research institute,  Spain.

Joan Vicent Sánchez Ortí is a Clinical Psychologist and Neuropsychologist currently working as a Research Technician at the Instituto de Investigación Sanitaria – INCLIVA. He is also a predoctoral researcher affiliated with CIBERSAM (Group 24, Universitat de València). His academic background includes a Bachelor’s degree in Psychology (2016), a Master’s in General Health Psychology (2019), and a Master’s in Basic and Applied Neurosciences (2021), all from Universitat de València. He is currently pursuing a Ph.D. in Medicine.

Profile

Google Scholar

Orcid

🧠 A Passion for Understanding the Mind

Joan Vicent Sánchez Ortí was born on August 6, 1994, with an innate curiosity about the complexities of human cognition. From an early age, he displayed a deep interest in psychology and neuroscience, which led him to pursue an academic path dedicated to unraveling the mysteries of the brain. His journey began at the Universitat de València, where he obtained his degree in Psychology in 2016. Motivated by his growing fascination with neuropsychology, he continued his studies, earning a Master’s in General Health Psychology in 2019 and a Master’s in Basic and Applied Neurosciences in 2021. His dedication to advancing medical science led him to enroll in an official Doctorate Program in Medicine at the same institution.

🏥 Bridging Psychology and Neuroscience in Professional Practice

Currently serving as a Neuropsychologist and Research Technician at the Health Research Institute (INCLIVA) in Spain, Joan Vicent plays a vital role in understanding cognitive impairments associated with severe mental disorders. His affiliation with the Biomedical Research Center in Mental Health Network (CIBERSAM) – Group 24 at the Universitat de València has allowed him to contribute significantly to groundbreaking studies. His expertise lies in assessing neurocognitive deficits, biomarkers, and epigenetic factors, aiming to enhance the diagnosis and treatment of psychiatric and neurological conditions.

🔬 Advancing Research in Neurocognitive Deficits and Mental Health

Joan Vicent’s research delves into the intricate connections between brain function, cognition, and mental health. His studies focus on identifying early biomarkers of cognitive decline, exploring epigenetic influences, and evaluating social functioning and quality of life in patients suffering from severe mental disorders. His contributions have been instrumental in improving the understanding of conditions such as schizophrenia, bipolar disorder, and neurodegenerative diseases, providing valuable insights for clinical interventions.

🏆 Recognized for Excellence in Neuroscience and Psychology

Through his commitment to scientific discovery, Joan Vicent has garnered recognition in the field of neuroscience and psychology. His contributions to neuropsychology and mental health research have positioned him as a promising figure in cognitive science. His work is widely acknowledged for its impact on the development of new therapeutic approaches and diagnostic techniques. With a strong academic and research background, he continues to be an influential voice in the study of cognitive impairment.

🌍 Impacting Lives Through Mental Health Research

Beyond academic achievements, Joan Vicent’s work has real-world implications, improving the quality of life for individuals facing cognitive challenges. His research contributes to developing more effective treatments, enhancing diagnostic accuracy, and fostering a better understanding of mental disorders. Through his role at INCLIVA and CIBERSAM, he actively collaborates with interdisciplinary teams, ensuring that his findings are translated into clinical practice, ultimately benefiting patients and healthcare professionals alike.

🚀 Paving the Way for Future Innovations in Neuropsychology

With a strong foundation in psychology, neuroscience, and medicine, Joan Vicent remains dedicated to pushing the boundaries of cognitive research. His ongoing studies aim to integrate cutting-edge techniques in neuroimaging, genetics, and artificial intelligence to refine the understanding of neurocognitive disorders. His ambition is to contribute to the development of personalized medicine, where treatments are tailored to an individual’s neurobiological and psychological profile, revolutionizing mental healthcare.

🔮 A Vision for a Healthier, Cognitively Resilient Future

Looking ahead, Joan Vicent Sánchez Ortí envisions a world where mental health is better understood, diagnosed, and treated with precision. His dedication to neuropsychology and cognitive research will continue to shape the future of mental healthcare, inspiring new generations of scientists and clinicians. As he advances in his career, his unwavering commitment to improving lives through research stands as a testament to his passion and perseverance in the field of neuroscience.

Publication

  • Manual motor speed dysfunction as a neurocognitive endophenotype in euthymic bipolar disorder patients and their healthy relatives. Evidence from a 5-year follow-up study
    P Correa-Ghisays, V Balanzá-Martínez, G Selva-Vera, J Vila-Francés, …
    2017

 

  • Grip Strength, Neurocognition, and social functioning in people With Type-2 diabetes mellitus, major depressive disorder, bipolar disorder, and schizophrenia
    M Aliño-Dies, JV Sanchez-Orti, P Correa-Ghisays, V Balanzá-Martinez, …
    2020

 

  • Visual memory dysfunction as a neurocognitive endophenotype in bipolar disorder patients and their unaffected relatives. Evidence from a 5-year follow-up Valencia study
    P Correa-Ghisays, JV Sánchez-Ortí, R Ayesa-Arriola, E Setién-Suero, …
    2019

 

  • Specific metabolic syndrome components predict cognition and social functioning in people with type 2 diabetes mellitus and severe mental disorders
    JV Sanchez‐Orti, V Balanzá‐Martinez, P Correa‐Ghisays, G Selva‐Vera, …
    2022

 

  • Immune–Inflammatory Biomarkers Predict Cognition and Social Functioning in Patients With Type 2 Diabetes Mellitus, Major Depressive Disorder, Bipolar Disorder, and …
    M Garés-Caballer, JV Sánchez-Ortí, P Correa-Ghisays, …
    2022

 

  • Probiotic, prebiotic, synbiotic and fermented food supplementation in psychiatric disorders: A systematic review of clinical trials
    C Ribera, JV Sánchez-Ortí, G Clarke, W Marx, S Mörkl, …
    2024

 

  • Transdiagnostic neurocognitive deficits in patients with type 2 diabetes mellitus, major depressive disorder, bipolar disorder, and schizophrenia: A 1-year follow-up study
    P Correa-Ghisays, JV Sanchez-Orti, V Balanza-Martinez, G Selva-Vera, …
    2022

 

  • Inflammation and lipid metabolism as potential biomarkers of memory impairment across type 2 diabetes mellitus and severe mental disorders
    JV Sanchez-Orti, P Correa-Ghisays, V Balanza-Martinez, G Selva-Vera, …
    2023

 

  • MICEmi: A method to identify cognitive endophenotypes of mental illnesses
    P Correa-Ghisays, JV Sanchez-Orti, V Balanza-Martinez, I Fuentes-Dura, …
    2022

 

  • Specific immune-inflammatory profiles and neurocognitive deficits predict illness trajectories in people with type 2 diabetes mellitus or psychiatric disorders
    JV Sanchez-Orti, P Correa-Ghisays, V Balanza-Martinez, G Selva-Vera, …
    2025

 

Conclusion 🎯

Joan Vicent Sánchez Ortí’s dedication to neuroscience and mental health research positions him as an influential figure in the field. His expertise bridges psychology, medicine, and genetics, offering innovative solutions for cognitive disorders. With a strong commitment to improving lives through research, his work has already made a meaningful impact and will continue to shape the future of mental healthcare, neuropsychology, and personalized medicine. As he advances in his career, his passion and contributions will undoubtedly lead to groundbreaking discoveries in cognitive science.